A Phase III, Multicenter, Double Blind, Randomized Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL
Condition:   Yellow Fever Interventions:   Biological: STAMARIL;   Biological: SII-YFV Sponsor:   Serum Institute of India Pvt. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL
Condition:   Yellow Fever Interventions:   Biological: STAMARIL;   Biological: SII-YFV Sponsor:   Serum Institute of India Pvt. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials